These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37502585)

  • 1. Retracted: G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9806936. PubMed ID: 37502585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retracted: IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer.
    Oncology JO
    J Oncol; 2023; 2023():9807856. PubMed ID: 37946722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: TTC7B Is a Novel Prognostic-Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9787264. PubMed ID: 37810555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9819147. PubMed ID: 37808149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9764352. PubMed ID: 37860436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Pan-Cancer Analysis of Prognostic and Immune Infiltrates for the TMEM65, Especially for the Breast Cancer.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9790580. PubMed ID: 38125110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9760920. PubMed ID: 38094413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: High SIRPA Expression Predicts Poor Prognosis and Correlates with Immune Infiltrates in Patients with Esophageal Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9758202. PubMed ID: 37860319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: Prognostic Value of Stem Cell Index-Related Characteristics in Primary Hepatocellular Carcinoma.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9850917. PubMed ID: 37502512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9806284. PubMed ID: 37565158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Identification and Validation of an Inflammatory Response-Related Polygenic Risk Score as a Prognostic Marker in Hepatocellular Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9809678. PubMed ID: 37538093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9754067. PubMed ID: 37501844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9815947. PubMed ID: 37565164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: Prognostic and Immunological Significance of FUNDC1 in Hepatocellular Carcinoma: A Study on TCGA Mining.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9818549. PubMed ID: 38077877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: Development and Optimization of a Prognostic Model Associated with Stemness Genes in Hepatocellular Carcinoma.
    International BR
    Biomed Res Int; 2024; 2024():9815950. PubMed ID: 38230074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Genome-Wide Screening Identifies Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma.
    International BR
    Biomed Res Int; 2023; 2023():9841321. PubMed ID: 38075334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma.
    International BR
    Biomed Res Int; 2024; 2024():9808126. PubMed ID: 38550199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor.
    Oncology JO
    J Oncol; 2023; 2023():9803262. PubMed ID: 37869587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9801756. PubMed ID: 37593684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9764203. PubMed ID: 38094457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.